Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)

MLA

Cheng, Hengmiao, et al. “Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195).” Journal of Medicinal Chemistry, vol. 64, no. 1, Jan. 2021, pp. 644–61. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.0c01652.

APA

Cheng, H., Orr, S. T. M., Bailey, S., Brooun, A., Chen, P., Deal, J. G., Deng, Y. L., Edwards, M. P., Gallego, G. M., Grodsky, N., Huang, B., Jalaie, M., Kaiser, S., Kania, R. S., Kephart, S. E., Lafontaine, J., Ornelas, M. A., Pairish, M., Planken, S., … Kath, J. C. (2021). Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195). Journal of Medicinal Chemistry, 64(1), 644–661. https://doi.org/10.1021/acs.jmedchem.0c01652

Chicago

Cheng, Hengmiao, Suvi T. M. Orr, Simon Bailey, Alexei Brooun, Ping Chen, Judith G. Deal, Yali L. Deng, et al. 2021. “Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195).” Journal of Medicinal Chemistry 64 (1): 644–61. doi:10.1021/acs.jmedchem.0c01652.